in ,

Leidos Gets Patent for Peptide-Class of Checkpoint Inhibitors

Leidos Gets Patent for Peptide-Class of Checkpoint Inhibitors - top government contractors - best government contracting event

Leidos Gets Patent for Peptide-Class of Checkpoint Inhibitors - top government contractors - best government contracting eventLeidos' life sciences unit has secured a U.S. patent for its new peptide-based PD-1 checkpoint inhibitors developed for more targeted delivery of treatments.

The company said Thursday that the U.S. Patent and Trademark Office issued the patent for Leidos Health Life Sciences through the Patents 4 Patients program.

The program provides a faster review process for cancer immunotherapy-related patent applications.

Gabriel Gutierrez, Leidos researcher and one of the developers, said the team utilized tools used to fight cancer to develop the checkpoint inhibitors to fight infectious diseases such as malaria and HIV.

“Peptides represented an ideal tool to achieve our goal and this patent represents an important milestone for us,” he said.

Leidos said peptides enable researchers to provide more targeted delivery of treatments as they serve as a therapeutic platform that can be genetically engineered into vaccines, oncolytic viruses and cellular therapies.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Products & Service

DHS, CBP Request Access to SpaceX South Texas Site for Survey - top government contractors - best government contracting event

DHS, CBP Request Access to SpaceX South Texas Site for Survey

Inmarsat, Collins Aerospace Form Inflight Internet Service Partnership - top government contractors - best government contracting event

Inmarsat, Collins Aerospace Form Inflight Internet Service Partnership